
Dr Heloisa Zaccaron Milioli
Dr Heloisa Helena Milioli completed her PhD from the University of Newcastle (UoN) in 2017 and pursued a postdoctoral training with Associate Professor Elgene Lim at the Connie Johnson Breast Cancer Research Laboratory, Garvan Institute of Medical Research. She was awarded the Cancer Institute of NSW Early-Career Fellowship (2018 – 2020) to study the interplay between sex steroid hormone receptors in cancer, with particular emphasis on novel therapeutic strategies for endocrine-resistant breast cancers.
Awards
- 2024St Vincent’s Research Week - Best Poster Award (EMCR). Sydney NSW - Australia
- 2022Estee Lauder Breast Cancer Award (AUD $10 - 000). Sydney NSW - Australia
- 2018Garvan Institute of Medical Research Travel Grant (AUD $1 - 000). EMCR Forum 2018. Sydney NSW - Australia
- 2016EMBL Australia PhD Travel Grant (AUD $3 - 000) - 18th EMBL PhD Symposium in Heildeberg - Germany. Australia
- 2016Young Scientist Award - 2nd World Congress on Controversies in Breast Cancer (CoBrCA). Barcelona - Spain
- 2015Bioinfosummer 2015 Travel Bursary (AUD $500) - Australian Mathematical Sciences Institute (AMSI) - Australia
- 2015BioInfoSummer 2015 - Best Poster Award. Sydney NSW - Australia
- 2015Hunter Cancer Research Alliance (HCRA) PhD RESEARCH AWARD 2016 (AUD $5 - 000). Newcastle NSW - Australia
- 2015Hunter Cancer Research Alliance (HCRA) Travel Grant (AUD $1 - 000). Newcastle NSW - Australia
- 2014BioInfoSummer 2014 - Best Poster Presentation. Melbourne VIC - Australia
- 2014International Conference on Bioinformatics (InCoB) - Best Poster Award. Sydney NSW - Australia
- 2014JENNIE THOMAS MEDICAL RESEARCH Travel Grant (AUD $10 - 000) - Hunter Medical Research Institute. Newcastle NSW - Australia
Selected publications
See all publications- 2024IScience10.1016/j.isci.2024.110116
Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.
- 2023BioRxiv : The Preprint Server for Biology10.1101/2023.09.30.558960
Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.